Showing 3501-3510 of 6035 results for "".
- Nicox Announces Publication of NCX 470 Results Demonstrating Improvements to Ocular Hemodynamics and Retinal Cell Physiologyhttps://modernod.com/news/nicox-announces-publication-of-ncx-470-results-demonstrating-improvements-to-ocular-hemodynamics-and-retinal-cell-physiology-1/2480951/Nicox SA announced that the results from studies on the beneficial effects of NCX 470 in a nonclinical model of endothelin-1 (ET-1)-induced ischemia/reperfusion damage of the optic nerve head and retina have been published online in the peer-reviewed Journal of Ocular Pharmacology and Therape
- MeiraGTx Announces Topline Data from the MGT009 Phase 1/2 Clinical Study Demonstrating Safety and Improvement in Vision in XLRP Patientshttps://modernod.com/news/meiragtx-announces-positive-topline-data-from-the-mgt009-phase-12-clinical-study-demonstrating-safety-and-improvement-in-vision-in-xlrp-patients/2480936/MeiraGTx Holdings announced topline data from the phase 1/2 clinical study MGT009 (
- OliX Pharmaceuticals Subsidiary mCureX Announces mRNA Technology Collaboration with ToolGen for Rare Eye Diseasehttps://modernod.com/news/olix-pharmaceuticals-subsidiary-mcurex-announces-mrna-technology-collaboration-with-toolgen-for-rare-eye-disease/2480920/OliX Pharmaceuticals, a\ developer of RNAi therapeutics, announced that the company’s subsidiary, mCureX Therapeutics, has recently signed a contract for joint research with ToolGen to advance the development of gene therapy for rare eye diseases, leveraging mCureX’s mRNA technol
- University of Wisconsin Eye Research Uncovers How Stem Cell Photoreceptors Reach Their Targetshttps://modernod.com/news/uw-eye-research-uncovers-how-stem-cell-photoreceptors-reach-their-targets/2480915/A new study reveals how photoreceptors grown from stem cells might extend biological wires, known as axons, to contact existing neurons. The finding has implications for future treatment of retinal diseases that cause blindness, including age-related macular degeneration (AMD) and rare disea
- CORE Study Shows Importance of Rub and Rinse Regimen for Coronavirus Removal from Contact Lens Materialshttps://modernod.com/news/core-study-shows-importance-of-rub-and-rinse-regimen-for-coronavirus-removal-from-contact-lens-materials/2480905/A new study conducted by the
- Aurion Biotech Appoints Michael Goldstein, MD, as President and Chief Medical Officerhttps://modernod.com/news/aurion-biotech-appoints-dr-michael-goldstein-as-president-and-chief-medical-officer/2480904/Aurion Biotech announced it has appointed Michael Goldstein, MD, as president and chief medical officer. Dr. Goldstein will lead the company’s clinical strategy, development and operations; medical affairs; and manufacturing and quality teams for its first product candidate, a cel
- NIH: Gene Therapy for Rare Eye Disease Safe But Lacks Efficacy in Early Trialhttps://modernod.com/news/nih-gene-therapy-for-rare-eye-disease-safe-but-lacks-efficacy-in-early-trial/2480896/A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, with even the highest dose. LHON affects the optic nerve, which carries vi
- The Vision Council Announces that Version 3.13 of the Data Communication Standard is Now Availablehttps://modernod.com/news/the-vision-council-announces-that-version-313-of-the-data-communication-standard-is-now-available/2480893/The Vision Council announced the publication of Version 3.13 of the Standard for Data Communications. The standard, which is used by manufacturers of optical lab equipment and producers of software used in optical labs, was developed by The Vision Council’s Lens Proce
- Market Scope: Global PC-IOL Demand Rises Modestly, Soars in a Few Countrieshttps://modernod.com/news/market-scope-global-pc-iol-demand-rises-modestly-soars-in-a-few-countries/2480888/Presbyopia-correcting IOLs experienced steady global growth in 2021 and record-breaking growth in a handful of countries, according to a Market Scope re
- "Artificial Intelligence in Ophthalmology 2022" Conference is Being Held Onlinehttps://modernod.com/news/artificial-intelligence-in-ophthalmology-2022-conference-is-being-held-online/2480884/The "Artificial Intelligence in Ophthalmology 2022" conference is being held online on June 3, 2022. The conference will feature an overview of artificial intelligence (AI), machine learning (ML) and deep learning (